BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35077844)

  • 21. [Megakaryopoiesis: regulation of platelet production by thrombopoietin].
    Vainchenker W; Besancenot R; Favale F
    Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.
    Machlus KR; Wu SK; Vijey P; Soussou TS; Liu ZJ; Shacham E; Unger TJ; Kashyap T; Klebanov B; Sola-Visner M; Crochiere M; Italiano JE; Landesman Y
    Blood; 2017 Aug; 130(9):1132-1143. PubMed ID: 28630120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
    Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
    Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
    Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation.
    Di Buduo CA; Currao M; Pecci A; Kaplan DL; Balduini CL; Balduini A
    Haematologica; 2016 Dec; 101(12):1479-1488. PubMed ID: 27515246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway.
    Ye JY; Chan GC; Qiao L; Lian Q; Meng FY; Luo XQ; Khachigian LM; Ma M; Deng R; Chen JL; Chong BH; Yang M
    Haematologica; 2010 Oct; 95(10):1745-53. PubMed ID: 20562316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-486-5p and miR-22-3p Enable Megakaryocytic Differentiation of Hematopoietic Stem and Progenitor Cells without Thrombopoietin.
    Kao CY; Jiang J; Thompson W; Papoutsakis ET
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGF-1 facilitates thrombopoiesis primarily through Akt activation.
    Chen S; Hu M; Shen M; Wang S; Wang C; Chen F; Tang Y; Wang X; Zeng H; Chen M; Gao J; Wang F; Su Y; Xu Y; Wang J
    Blood; 2018 Jul; 132(2):210-222. PubMed ID: 29802222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice.
    Bender M; Giannini S; Grozovsky R; Jönsson T; Christensen H; Pluthero FG; Ko A; Mullally A; Kahr WH; Hoffmeister KM; Falet H
    Blood; 2015 Feb; 125(6):1014-24. PubMed ID: 25468568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
    Deutsch VR; Tomer A
    Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.
    Abraham M; Weiss ID; Wald H; Wald O; Nagler A; Beider K; Eizenberg O; Peled A
    Br J Haematol; 2013 Oct; 163(2):248-59. PubMed ID: 23906028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway.
    Kauskot A; Vandenbriele C; Louwette S; Gijsbers R; Tousseyn T; Freson K; Verhamme P; Hoylaerts MF
    Blood; 2013 Jun; 121(26):5208-17. PubMed ID: 23667054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.
    Chanprasert S; Geddis AE; Barroga C; Fox NE; Kaushansky K
    Cell Signal; 2006 Aug; 18(8):1212-8. PubMed ID: 16380230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
    Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
    Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologic role of TPO in thrombopoiesis.
    Miyazaki H
    Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse prenatal platelet-forming lineages share a core transcriptional program but divergent dependence on MPL.
    Potts KS; Sargeant TJ; Dawson CA; Josefsson EC; Hilton DJ; Alexander WS; Taoudi S
    Blood; 2015 Aug; 126(6):807-16. PubMed ID: 25995324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKC-epsilon deficiency alters progenitor cell populations in favor of megakaryopoiesis.
    Kostyak JC; Liverani E; Kunapuli SP
    PLoS One; 2017; 12(8):e0182867. PubMed ID: 28783756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.